Theratechnologies Earnings Preview
Portfolio Pulse from Benzinga Insights
Theratechnologies (NASDAQ:THTX) is expected to report a Q4 EPS of $-0.24 on February 21, 2024. Analysts and investors will be looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Currently, shares are trading at $1.65, down 57.73% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

February 20, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Theratechnologies is anticipated to report a Q4 EPS of $-0.24, with investors looking for an earnings beat and positive future guidance. The stock has been bearish with a 57.73% decline over the past year.
The expected EPS and the anticipation of positive guidance are key factors that could influence THTX's stock price in the short term. However, the stock's recent bearish trend and the mixed past earnings performance introduce uncertainty, leading to a neutral score. The relevance is high as the news directly pertains to THTX's financial performance. The importance is also high given the potential impact of earnings reports on stock prices, but the mixed historical performance and current bearish sentiment temper the confidence in predicting a clear direction.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100